Advanced NanoTherapies

Drug-coated balloons engineered to deliver stent-like patency and restenosis prevention with long-term release of synergistic drugs.

Launch date

2018

Employees

Market cap

Net debt

Enterprise valuation

$36m (Public information from Aug 2023)

Mountain View California (HQ)

Get premium to view all results

Date	Investors	Amount	Round
Nov 2019	investor investor	$0.0 Valuation: $0.0	round
Jun 2022	N/A	$0.0	round
Aug 2023*	N/A	$4.0m Valuation: $36.0m	Series A
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Advanced NanoTherapies